AcouSort publishes additional application notes before participating in ISEV 2019 in Japan

AcouSort AB (publ) (“AcouSort”) continues to develop a series of application notes which are brief descriptions of typical customer applications. Two new applications have just been published describing how AcouTrap can be used to isolate and manage extracellular vesicles. The application notes demonstrate how effective AcouTrap is compare to earlier methods. The material is published… Read more »

Read More

Q&A with CEO Torsten Freltoft

AcouSort AB (publ) (“AcouSort”) is in an intensive period with many exciting projects in the pipeline. In light of this, the company has received a number of questions from both existing and potential shareholders. AcouSort has gathered some of the questions and let CEO Torsten Freltoft provide an update on the status of the various… Read more »

Read More

AcouSort partner in multi-million initiative on cell and gene therapy

AcouSort AB (publ) (“AcouSort”) today announces that the company is a partner in the Center for Advanced Medical Products (CAMP). AcouSort participates in a project with the aim of finding new methods for separating stem cells and other regenerative cell types from bone marrow and fat tissue in order to be able to use the… Read more »

Read More